Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
批准号:
10614436
负责人:
VINCENT T LEE
金额:
$19.07万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2025-04-30
关键词:
Bacterial AdhesinsBindingBinding ProteinsBiochemicalBiological AssayBlood capillariesCellsCharacteristicsChemotaxisCyclic AMPCyclic GMPDNA StructureDefectDevelopmentDinucleoside PhosphatesDisadvantagedDown-RegulationEnzymesEscherichia coliFamilyGenesGeneticGenetic TranscriptionGenomeHemagglutininHomeostasisHorizontal Gene TransferIndividualInfantInfectionIslandLigandsMannoseMediatingMetabolismMutateNucleotidesOpen Reading FramesOperonOrganismPathogenesisPathogenicityPathway interactionsPeriodicityPhospholipasePhospholipases APilumProcessProductionProkaryotic CellsProteinsProteomicsPyruvate CarboxylaseRNARadialRadiolabeledRegulationRegulatory PathwayRegulonReportingRepressionScanningSignal PathwaySignal TransductionSignaling MoleculeSingle Nucleotide PolymorphismSmall RNAStructureSurfaceTechniquesTestingVibrioVibrio choleraeVirulenceaffinity labelingbiotypescellulose synthasegenetic approachlipid metabolismmouse modelmutantoverexpressionpandemic diseasepathogenpotassium ionpromoterreceptorscreeningtranscription factor
中文摘要
摘要
霍乱弧菌是一种能够引起全球大流行的病原体,包括
科学记录。第七次大流行El Tor生物型取代了经典的
导致前六次大流行的生物型在基因上有许多不同
核苷酸多态与七号弧菌两个大基因岛的获得
大流行岛屿I和II(VSP-I和VSP-II)。VSP-I岛编码11个基因,
包括dncv,它编码一种二核苷酸环化酶,产生环状-
GMP-AMP(CGAMP)分子。对感染幼鼠模型的毒力研究揭示
Dncv是VSP-I中唯一的基因,当突变时,具有竞争劣势。
与亲本菌株相比。这为DncV和cGAMP提供了强有力的证据
对致死性很重要。CGAMP如何调节下游途径增强毒力
仍然悬而未决。最近,一项研究发现,VSP-I中的另一个基因称为capV,即
紧邻dncv,编码一种磷脂酶,通过结合激活
CGAMP。这些结果表明,cGAMP通过与细胞内蛋白受体结合而作用于细胞。
在概念上类似于其他环二核苷酸的方式。而CapV的发现
解释了DncV和cGAMP对霍乱弧菌脂代谢的影响,以及
CGAMP对毒力、MSHA表达和趋化性表达的影响尚不清楚。这
建议假设额外的蛋白受体(S)直接与cGAMP结合介导
MSHA的下游调控、趋化作用和发病机制。我们将检验我们的假设
通过使用生化和遗传方法,包括:目标1.识别相互作用
CGAMP和AIM的蛋白质2.cGAMP下调MSHA的特性
歌剧。总之,完成这一目标的结果将揭示cGAMP信号如何
出现在霍乱弧菌中,并揭示了cGAMP和cGMP-di-GMP之间的交点
(C-di-GMP),霍乱弧菌也使用的另一种环二核苷酸分子。此外,
揭示霍乱弧菌中的信号分子网络将有助于更好地理解
当病原体通过水平基因转移获得cGAMP信号时,它们可以适应。
英文摘要
ABSTRACT
Vibrio cholerae is a pathogen capable of causing worldwide pandemics including seven in
the scientific record. The seventh pandemic El Tor biotype that displaced the classical
biotype responsible for the first six pandemics differ genetically by many single
nucleotide polymorphisms and the acquisition of two large genetic islands called Vibrio seventh
pandemic islands I and II (VSP-I and VSP-II). The VSP-I island encodes eleven genes,
including dncV which encodes a dinucleotide cyclase enzyme that produces the cyclic-
GMP-AMP (cGAMP) molecule. Virulence studies in the infant mice model of infection revealed
that dncV is the only gene in VSP-I, that when mutated, has a competitive disadvantage
compared to the parental strain. This provides strong evidence that DncV and cGAMP is
important for virulence. How cGAMP regulated downstream pathways to enhance virulence
remained unresolved. Recently, a study revealed that another gene in VSP-I called capV, that is
immediately adjacent to dncV, encodes a phospholipase that is activated by binding to
cGAMP. These results suggest that cGAMP acts on the cell by binding protein receptors in
a manner similar in concept of other cyclic dinucleotides. While the discover of CapV
explained the effect of DncV and cGAMP on lipid metabolism in V. cholerae, the effect of
cGAMP on virulence, MSHA expression and chemotaxis expression are unexplained. This
proposal hypothesizes that additional protein receptor(s) bind directly to cGAMP to mediate
downstream regulation of MSHA, chemotaxis and pathogenesis. We will test our hypothesis
by using biochemical and genetic approaches including: Aim 1. Identifying interacting
proteins of cGAMP and Aim 2. Characterizing cGAMP down regulation of the MSHA
operons. Together, results from the completion of this aim will reveal how cGAMP signaling
occurs in V. cholerae and shed light on the intersection between cGAMP and cyclic-di-GMP
(c-di-GMP), another cyclic dinucleotide molecule also used by V. cholerae. In addition,
revealing the network of signaling molecules in V. cholerae will allow better understand of
pathogens can adapt when they acquire cGAMP signaling via horizontal gene transfer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
-
批准号:10371521
-
项目类别:
-
资助金额:$22.01万
-
财政年份:2022
-
负责人:VINCENT T LEE
-
依托单位:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
-
批准号:10620734
-
项目类别:
-
资助金额:$58.02万
-
财政年份:2019
-
负责人:VINCENT T LEE
-
依托单位:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
-
批准号:10163122
-
项目类别:
-
资助金额:$57.78万
-
财政年份:2019
-
负责人:VINCENT T LEE
-
依托单位:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
-
批准号:10410509
-
项目类别:
-
资助金额:$57.9万
-
财政年份:2019
-
负责人:VINCENT T LEE
-
依托单位:
High-throughput assay for protein-ligand interaction
-
批准号:8176077
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2011
-
负责人:VINCENT T LEE
-
依托单位:
High-throughput assay for protein-ligand interaction
-
批准号:8263370
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2011
-
负责人:VINCENT T LEE
-
依托单位:
Training in Host-Pathogen Interactions
-
批准号:10473782
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2010
-
负责人:VINCENT T LEE
-
依托单位:
Training in Host-Pathogen Interactions
-
批准号:10630267
-
项目类别:
-
资助金额:$13.99万
-
财政年份:2010
-
负责人:VINCENT T LEE
-
依托单位:
Training in Host-Pathogen Interactions
-
批准号:10270658
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2010
-
负责人:VINCENT T LEE
-
依托单位:
Small molecule inhibitors of bacterial secretion system
-
批准号:7337974
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2007
-
负责人:VINCENT T LEE
-
依托单位:
Small molecule inhibitors of bacterial secretion system
-
批准号:7092748
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2007
-
负责人:VINCENT T LEE
-
依托单位:
Host genes required for P. aeruginosa pathogenesis
-
批准号:6551177
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2002
-
负责人:VINCENT T LEE
-
依托单位:
Host genes required for P. aeruginosa pathogenesis
-
批准号:6751332
-
项目类别:
-
资助金额:$4.89万
-
财政年份:2002
-
负责人:VINCENT T LEE
-
依托单位:
Host genes required for P. aeruginosa pathogenesis
-
批准号:6640497
-
项目类别:
-
资助金额:$4.64万
-
财政年份:2002
-
负责人:VINCENT T LEE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: